CSIR Central

Synergistic Effect of Interferon-g and Mannosylated Liposome-Incorporated Doxorubicin in the Therapy of Experimental Visceral Leishmaniasis

IR@IICB: CSIR-Indian Institute of Chemical Biology, Kolkata

View Archive Info
 
 
Field Value
 
Title Synergistic Effect of Interferon-g and Mannosylated Liposome-Incorporated Doxorubicin in the Therapy of Experimental Visceral Leishmaniasis
 
Creator Kole, Labanyamoy
Das, Lopamudra
Das, Pijush K
 
Subject Infectious Diseases and Immunology
 
Description Active targeting of doxorubicin to macrophages was studied by incorporating it in mannosecoated liposomes by use of visceral leishmaniasis in BALB/c mice as the model macrophage disease. Mannosylated liposomal doxorubicin was more effective than liposomal doxorubicin or free doxorubicin. Because leishmaniasis is accompanied by immunosuppression, immunostimulation by interferon (IFN)–g was evaluated to act synergistically with mannosylated liposomal doxorubicin therapy. Combination chemotherapy with a suboptimal dose of IFNg resulted in possibly complete elimination of spleen parasite burden. Analysis of mRNA levels of infected spleen cells suggested that targeted drug treatment together with IFN-g, in addition to greatly reducing parasite numbers, resulted in reduced levels of interleukin (IL)–4 but increased levels of IL-12 and inducible nitric oxide synthase. Such combination chemotherapy may provide a promising alternative for the cure of leishmaniasis, with a plausible conversion of antiparasitic T cell response from a Th2 to Th1 pattern indicative of long-term resistance.
 
Publisher University of Chicago Press
 
Date 1999
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/688/1/JOURNAL_OF_INFECTIOUS_DISEASES__180(_3)_811%2D820;1999[25].pdf
Kole, Labanyamoy and Das, Lopamudra and Das, Pijush K (1999) Synergistic Effect of Interferon-g and Mannosylated Liposome-Incorporated Doxorubicin in the Therapy of Experimental Visceral Leishmaniasis. The Journal of Infectious Diseases, 180 (3). pp. 811-820.
 
Relation http://dx.doi.org/ 10.1086/314929
http://www.eprints.iicb.res.in/688/